Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NVO

Novo Nordisk ADR

Dec 26 • 02:17PM ET

87.88

Dollar change +0.51
Percentage change 0.58	%

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY PFE MRK ABBV BMY JNJ AMGN REGN GILD VRTX

| Held by: AVDE PPH NUGO DFIC FBCG APIE PID ULTY OZEM DFAI

Scroll to Statements

Index	-	P/E	28.50	EPS (ttm)	3.08	Insider Own	0.03%	Shs Outstand	3.34B	Perf Week	-17.07%
Market Cap	293.37B	Forward P/E	22.20	EPS next Y	3.96	Insider Trans	0.00%	Shs Float	3.34B	Perf Month	-15.96%
Income	13.78B	PEG	2.59	EPS next Q	0.88	Inst Own	9.99%	Short Float	0.14%	Perf Quarter	-29.30%
Sales	39.33B	P/S	7.46	EPS this Y	18.56%	Inst Trans	-0.93%	Short Ratio	0.75	Perf Half Y	-39.18%
Book/sh	5.40	P/B	16.26	EPS next Y	23.03%	ROA	26.99%	Short Interest	4.70M	Perf Year	-14.42%
Cash/sh	3.36	P/C	26.17	EPS next 5Y	11.00%	ROE	88.20%	52W Range	81.50 - 148.15	Perf YTD	-15.05%
Dividend Est.	1.56 (1.77%)	P/FCF	25.89	EPS past 5Y	16.48%	ROI	53.52%	52W High	-40.68%	Beta	0.42
Dividend TTM	1.45 (1.65%)	Quick Ratio	0.75	Sales past 5Y	14.25%	Gross Margin	84.66%	52W Low	7.82%	ATR (14)	3.72
Dividend Ex-Date	Aug 16, 2024	Current Ratio	0.94	EPS Y/Y TTM	28.07%	Oper. Margin	43.87%	RSI (14)	27.36	Volatility	3.46% 2.19%
Employees	63370	Debt/Eq	0.47	Sales Y/Y TTM	27.73%	Profit Margin	35.03%	Recom	1.87	Target Price	129.94
Option/Short	Yes / Yes	LT Debt/Eq	0.43	EPS Q/Q	23.30%	Payout	36.03%	Rel Volume	0.86	Prev Close	87.37
Sales Surprise	-2.85%	EPS Surprise	0.19%	Sales Q/Q	22.49%	Earnings	Nov 06 BMO	Avg Volume	6.26M	Price	87.88
SMA20	-15.56%	SMA50	-18.18%	SMA200	-30.02%	Trades		Volume	4,017,079	Change	0.58%

Date	Action	Analyst	Rating Change	Price Target Change
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-28-22	Downgrade	UBS	Neutral → Sell
Jun-27-22	Upgrade	Exane BNP Paribas	Underperform → Neutral
Jun-07-22	Upgrade	JP Morgan	Neutral → Overweight
May-31-22	Upgrade	Guggenheim	Neutral → Buy
Apr-25-22	Upgrade	Cowen	Market Perform → Outperform	$130
Apr-12-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-16-22	Upgrade	Deutsche Bank	Hold → Buy
Jan-25-22	Downgrade	Liberum	Hold → Sell
Dec-20-21	Downgrade	JP Morgan	Overweight → Neutral
Dec-17-21	Downgrade	Deutsche Bank	Buy → Hold
Jan-20-21	Downgrade	Credit Suisse	Outperform → Neutral
Jan-15-21	Initiated	Deutsche Bank	Buy

Show Previous Ratings

Today 10:15AM	Better Buy: Eli Lilly vs. Novo Nordisk. The Answer Is Becoming Abundantly More Clear. (Motley Fool)
09:36AM	Elon Musk's Weight-Loss Secret Shakes Up Pharma Giants (GuruFocus.com)
08:00AM	Down 19% in 1 Day, Is Novo Nordisk Stock Still a Buy? (Motley Fool)
Dec-25-24 07:12AM	Jim Cramer Says Novo Nordisk A/S (NVO) Can't Exceed Eli Lilly (Insider Monkey)
06:30AM	Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst (Yahoo Finance Video)
05:45PM	Loading…
Dec-24-24 05:45PM	Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
02:45PM	What's next for GLP-1 weight-loss drugs in 2025? (Yahoo Finance Video)
12:20PM	3 biggest catalysts expected for healthcare in 2025 (Yahoo Finance Video)
09:38AM	Retail investors buy Novo dip after disappointing weight-loss drug data (Reuters)
07:12AM	Novo gets the green light for once-daily haemophilia drug following setbacks (Pharmaceutical Technology)
Dec-23-24 03:46PM	Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. (Barrons.com)
11:38AM	European Stocks Edge Higher as Novo Nordisk Jumps From 2023 Low (Bloomberg)
11:36AM	Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea (Investopedia)
10:25AM	Xerox-Lexmark, Novo Nordisk, News Corp: 3 stories in focus (Yahoo Finance Video)
07:22AM	Hot Obesity Drug Market Will Keep Investors Gripped Next Year (Bloomberg)
06:49AM	Loading…
06:49AM	Asian, European Markets Gain as Novo Nordisk Shines (Barrons.com)
Dec-22-24 06:45AM	Is Merck the Next Big Weight-Loss Stock? (Motley Fool)
Dec-21-24 07:30AM	Novo obesity data positive for Eli Lilly and Amgen, says UBS (TipRanks)
07:25AM	Jefferies sees Novo dropping at least 10%-15% on obesity data (TipRanks)
07:25AM	Weight loss seen with Novos CagriSema weaker than expected, says BofA (TipRanks)
06:48AM	3 Fantastic Stocks That Could Enjoy a Santa Claus Rally (Motley Fool)
04:55AM	Is Now a Good Time to Buy the Dip in Eli Lilly Stock? (Motley Fool)
Dec-20-24 08:27PM	Analyst Report: Novo Nordisk A/S (Morningstar Research) -17.83%
05:59PM	Novo Nordisk Stock Crashes on Obesity Drug Data. Its a Win for Eli Lilly. (Barrons.com)
05:44PM	BMO's Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints (CNBC TV)
04:11PM	Novo Crashes After Obesity Drug Misses Lofty Expectations. Lilly, Viking And Amgen Surge. (Investor's Business Daily)
04:02PM	Stock Market Today: Dow Jones, Other Indexes Rebound But Trim Gains; Nvidia Climbs After Bullish Report (Live Coverage) (Investor's Business Daily)
03:21PM	Stock Market Today: Dow Jones Soars As Nvidia Bounces; Speaker Johnson Promises This (Live Coverage) (Investor's Business Daily)
02:05PM	Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture (CNBC TV)
01:27PM	Top Stock Movers Now: Carnival, US Steel, Occidental Petroleum, and More (Investopedia)
01:09PM	Loading…
01:09PM	Novos Obesity Shot Shortfall Shows Danger of Promising Too Much (Bloomberg)
12:57PM	Stocks suffer as Trump calls for US shutdown to begin now (The Telegraph)
12:20PM	Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up (Motley Fool)
11:52AM	Novo Crashes 19% After New Obesity Drug Misses Forecasts. Lilly, Viking, Amgen Jump. (Investor's Business Daily)
11:45AM	European Stocks Suffer Worst Week Since September as Novo Sinks (Bloomberg)
11:44AM	Novo Nordisk's Ozempic Wins Approval in Europe for Chronic Kidney Disease (GuruFocus.com)
11:38AM	Ozempic makers shares plunge after failed weight-loss trial (The Telegraph)
11:09AM	Novo Nordisk's New Weight-Loss Drug Lags Behind Eli Lilly's Zepbound (GuruFocus.com)
11:03AM	Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results (Yahoo Finance)
11:03AM	Novo Nordisk stock sees biggest loss in 20 years on CagriSema results (Yahoo Finance)
10:39AM	A next-gen Ozempic falls short in a drug trial and Novo Nordisk stock plunges 20% (Quartz)
10:31AM	Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? (Investor's Business Daily)
10:23AM	Novo Nordisk Plunges 20% After Weight-Loss Drug Trial Misses Target (GuruFocus.com)
10:14AM	Why Novo Nordisk (NVO) Is Plummeting Today (Insider Monkey)
10:03AM	Novo Nordisk takes a hit as CagriSema underperforms in weight loss (Clinical Trials Arena)
09:39AM	Novo Nordisk stock plunges on obesity shot trial results (Yahoo Finance Video)
09:15AM	November PCE, govt. shutdown looms, Novo Nordisk: 3 Things (Yahoo Finance Video)
08:33AM	Novo Nordisk Falls Most on Record After New Weight Drug Disappoints (Bloomberg)
08:17AM	Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. (Investor's Business Daily)
08:03AM	Novo Nordisk Sinks on Disappointing Trial Results for Next Gen Weight Loss Drug (Investopedia)
08:00AM	Is Eli Lilly Stock A Buy After FDA Pushes Back On Compounded Knockoffs? (Investor's Business Daily)
07:47AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
07:18AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:08AM	Novo Nordisk Stock Crashes More Than 20% After Disappointing Obesity Drug Data. Eli Lilly Shares Soar. (Barrons.com)
05:51AM	Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints (Reuters)
05:41AM	Novo Nordisk A/S: CagriSema demonstrates superior weight loss in adults with obesity or overweight in the REDEFINE 1 trial (GlobeNewswire)
02:06AM	Novos next-gen obesity drug misses expectations in closely watched trial (BioPharma Dive)
Dec-19-24 08:03PM	In weight loss battle, Novo and Lilly face growing offensive from licensed copies (Reuters)
04:21PM	Novo Is Ready to Ramp Up GLP-1 Manufacturing Following $11B Factory Deal (Barrons.com)
04:18PM	IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List (Investor's Business Daily)
03:57PM	FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next (Yahoo Finance)
09:06AM	Novo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints (Insider Monkey)
06:15AM	Got $250? 2 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
04:44AM	This Is Huge News for Eli Lilly Investors (Motley Fool)
Dec-18-24 10:27AM	Elon Musk, RFK, Dr. Oz and the coming clash over Ozempic (Yahoo Finance)
10:27AM	Elon Musk, RFK Jr., Dr. Oz, and the coming clash over Ozempic (Yahoo Finance)
08:59AM	The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed (GlobeNewswire)
06:15AM	Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug (Motley Fool)
Dec-17-24 11:45AM	Novo Nordisk invests $1.2bn in new Denmark facility (Pharmaceutical Technology)
09:00AM	Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:51AM	Is Novo Nordisk A/S (NVO) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
12:00AM	Novo Nordisks Hiring Binge Leaves Danish Firms Starved of Labor (Bloomberg)
Dec-16-24 05:03PM	Novos New Deal May End Wegovy Shortages. It Could Reshape the Pharma Industry Along the Way. (Barrons.com)
11:35AM	Novo Nordisk (NVO) To Diversify Revenue Streams With $1.2bn Investment In Denmark (Insider Monkey)
08:47AM	The Weight-Loss Drug Market Is Heading for a Reckoning This Week (Barrons.com)
08:32AM	Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent (Benzinga)
07:52AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
01:47AM	Novo Nordisk invests $1.2 billion in new rare disease drugs plant in Denmark (Reuters)
01:29AM	Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark (GlobeNewswire)
Dec-15-24 08:30AM	Nvidia, GM, Walmart, Palantir, Tesla, Meta, and others battle this Yahoo Finance awards season (Yahoo Finance)
08:17AM	Did Eli Lilly Just Say "Checkmate" to Novo Nordisk? (Motley Fool)
Dec-14-24 11:53AM	Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say (Reuters)
12:08AM	Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close (GlobeNewswire)
Dec-13-24 05:45PM	Novo Nordisk (NVO) Stock Moves -1.53%: What You Should Know (Zacks)
03:54PM	Novo Nordisk's Ozempic reportedly linked to vision loss in new study (Yahoo Finance Video)
01:44PM	Ozempic could be linked to a common cause of sudden blindness, study finds (Quartz)
12:20PM	Ozempic could be linked to a common cause of sudden blindness, another study finds (Quartz)
11:12AM	Ozempic Link to Rare Vision Loss Risk Confirmed in Study (Bloomberg)
10:03AM	Ozempic Works on Kidney Disease, Regulator Says. Why Novo Nordisk Stock Is Falling. (Barrons.com)
05:03AM	3 Growth Stocks That Can Be No-Brainer Buys in 2025 (Motley Fool)
Dec-12-24 09:46AM	Heres Why Novo Nordisk A/S (NVO) Fell in Q3 (Insider Monkey)
09:38AM	Telehealth Firm Ro Partners With Eli Lilly to Boost Access to Obesity Drug Zepbound (Benzinga)
08:47AM	Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events (GlobeNewswire)
Dec-11-24 11:24AM	What can't weight-loss meds do? Eli Lilly is going to test obesity drugs as a treatment for addiction (Quartz)
09:50AM	Ro partners with Eli Lilly to expand access to Zepbound vials (Yahoo Finance)
03:00AM	GLP-1 compounding is still in limbo. Will the FDA leave it for the next administration? (Pharma Voice)
Dec-10-24 04:10AM	Warning: This Skyrocketing Stock Has a Hidden Risk (Motley Fool)
Dec-09-24 12:44PM	Novo Nordisk Just Got One Step Closer to Resolving Wegovy Supply Issue (Barrons.com)
10:43AM	Novo Nordisk A/S - share repurchase programme (GlobeNewswire)
04:59AM	Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now (Motley Fool)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience